紧凑的Cas9替代品可以实现更有效的治疗

Q4 Biochemistry, Genetics and Molecular Biology

Genetic Engineering & Biotechnology News Pub Date : 2023-11-01 DOI:10.1089/gen.43.11.03

{"title":"紧凑的Cas9替代品可以实现更有效的治疗","authors":"","doi":"10.1089/gen.43.11.03","DOIUrl":null,"url":null,"abstract":"Genetic Engineering & Biotechnology NewsVol. 43, No. 11 News & AnalysisCompact Cas9 Alternative Could Enable More Effective TherapiesPublished Online:9 Nov 2023https://doi.org/10.1089/gen.43.11.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article\"Compact Cas9 Alternative Could Enable More Effective Therapies.\" Genetic Engineering & Biotechnology News, 43(11), p. 12FiguresReferencesRelatedDetails Volume 43Issue 11Nov 2023 Information© 2023 by GEN PublishingTo cite this article:Compact Cas9 Alternative Could Enable More Effective Therapies.Genetic Engineering & Biotechnology News.Nov 2023.12-12.http://doi.org/10.1089/gen.43.11.03Published in Volume: 43 Issue 11: November 9, 2023PDF download","PeriodicalId":50425,"journal":{"name":"Genetic Engineering & Biotechnology News","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Compact Cas9 Alternative Could Enable More Effective Therapies\",\"authors\":\"\",\"doi\":\"10.1089/gen.43.11.03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Genetic Engineering & Biotechnology NewsVol. 43, No. 11 News & AnalysisCompact Cas9 Alternative Could Enable More Effective TherapiesPublished Online:9 Nov 2023https://doi.org/10.1089/gen.43.11.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article\\\"Compact Cas9 Alternative Could Enable More Effective Therapies.\\\" Genetic Engineering & Biotechnology News, 43(11), p. 12FiguresReferencesRelatedDetails Volume 43Issue 11Nov 2023 Information© 2023 by GEN PublishingTo cite this article:Compact Cas9 Alternative Could Enable More Effective Therapies.Genetic Engineering & Biotechnology News.Nov 2023.12-12.http://doi.org/10.1089/gen.43.11.03Published in Volume: 43 Issue 11: November 9, 2023PDF download\",\"PeriodicalId\":50425,\"journal\":{\"name\":\"Genetic Engineering & Biotechnology News\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genetic Engineering & Biotechnology News\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/gen.43.11.03\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic Engineering & Biotechnology News","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/gen.43.11.03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}

引用次数: 0

摘要

基因工程与生物技术新闻卷。43、第11号新闻与分析紧凑的Cas9替代方案可以实现更有效的治疗在线发布:2023年11月9日https://doi.org/10.1089/gen.43.11.03AboutSectionsView文章查看全文pdf /EPUB权限和CitationsPermissionsDownload CitationsTrack citations添加到收藏夹回到出版物分享分享在facebook上推特链接在redditemail查看文章“紧凑的Cas9替代方案可以实现更有效的治疗。”基因工程与生物技术新闻，43(11)，p. 12 figureresreferencesrelateddetails卷43 issue 11Nov 2023信息©2023 by GEN publishing引用这篇文章:Compact Cas9替代品可以使更有效的治疗。基因工程与生物技术新闻。Nov 2023.12-12.http://doi.org/10.1089/gen.43.11.03Published in Volume: 43 Issue 11:十一月9,2023PDF下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Compact Cas9 Alternative Could Enable More Effective Therapies

Genetic Engineering & Biotechnology NewsVol. 43, No. 11 News & AnalysisCompact Cas9 Alternative Could Enable More Effective TherapiesPublished Online:9 Nov 2023https://doi.org/10.1089/gen.43.11.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Compact Cas9 Alternative Could Enable More Effective Therapies." Genetic Engineering & Biotechnology News, 43(11), p. 12FiguresReferencesRelatedDetails Volume 43Issue 11Nov 2023 Information© 2023 by GEN PublishingTo cite this article:Compact Cas9 Alternative Could Enable More Effective Therapies.Genetic Engineering & Biotechnology News.Nov 2023.12-12.http://doi.org/10.1089/gen.43.11.03Published in Volume: 43 Issue 11: November 9, 2023PDF download

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物

CiteScore

0.20

自引率

0.00%

发文量

210

审稿时长

3-6 weeks

期刊介绍： Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.